4/A
Changes in Ownership
SAB Biotherapeutics, Inc. Filed Acc 0001493152-21-029528
Options or other derivatives
- Director acquired 151,333 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/ownership.xml…